Ethics approval and consent to participate
All patients provided written informed consent. This trial was conducted in accordance with the Good Clinical Practice guidelines and Declaration of Helsinki. An independent ethics committee or institutional review board at each site approved the study protocol and any modifications. The study conduct was supervised by a steering committee comprising participating investigators and Novartis representatives. The safety data were assessed by an independent data monitoring committee.